skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Sunday, June 7, 2020

COVID-19 - How To Protect Yourself And Others - CDC.gov

The pandemic is not over yet!


The CDC tells us:

How to Protect Yourself & Others



Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Designated Rep Certification Class
CA Designated Representative Training Program
California Designated Representative Training Program
California HMDR Exemptee Training
Exemptee Certification Class
FL CDR Exam Prep
SkillsPlus Intl Inc. - The Leader in Compliance Training
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 5:57 AM
Labels: cdc, COVID, guidelines, recommendations

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

Loading...
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course

SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2025 #2026 #2027

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2025

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2025 #2026 #2027

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • Medscape Today Headlines
    5 Tips to Use Social Prescription to Support Lonely Patients
    1 hour ago
  • Marler Blog
    WTF? ByHart Botulism Infant Formula still on Store Shelves
    3 hours ago
  • FDA What's New: Drugs
    Drug Trials Snapshots: DAWNZERA
    12 hours ago
  • FierceBiotech: Medtech
    Tela Bio sues BD over hernia mesh monopoly claims
    13 hours ago
  • eLearning Industry
    How To Foster Holiday Inclusivity In Your Online Classroom
    13 hours ago
  • FierceBiotech
    Windtree offloads cardio pipeline, Vaccinex secures $60M funding in continued holiday shopping spree
    14 hours ago
  • FiercePharma
    Baltimore jury orders J&J to pay $1.5B in largest-ever award to a talc plaintiff
    14 hours ago
  • CNBC Health Care
    Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
    15 hours ago
  • GEN Biotech News
    SomaScan Surveying the Breadth and Depth of the Human Proteome
    17 hours ago
  • Pharmaceutical Commerce
    17 hours ago
  • BioPharma Dive - Latest News
    Novo Nordisk’s weight loss pill approved by FDA
    17 hours ago
  • BioPharma Dive
    Novo Nordisk’s weight loss pill approved by FDA
    17 hours ago
  • Pharmalot – STAT
    STAT+: We’re reading about the first approved GLP-1 pill, deal-hungry Ipsen, and more
    19 hours ago
  • Clarkston Consulting
    Top Program and Project Management Insights from 2025
    20 hours ago
  • Drug & Device Law
    You Can’t Outrun Preemption
    22 hours ago
  • Government Executive
    The twists and turns of Trump’s 2025 war on unions
    22 hours ago
  • NPR Blogs: Shots - Health News Blog
    It's the 'gold standard' in autism care. Why are states reining it in?
    22 hours ago
  • Wellness Blog - NY Times
    What Is a Grief Attack?
    23 hours ago
  • All Kaiser Health News
    It’s the ‘Gold Standard’ in Autism Care. Why Are States Reining It In?
    23 hours ago
  • Science-Based Medicine
    The FDA’s Proposed “Black Box” Warning for COVID-19 Vaccines
    1 day ago
  • Food Poison Journal
    Tokyo Stop Teriyaki linked to E. coli
    1 day ago
  • Medtech Insight
    Infographic: Ireland’s Medtech Industry, By The Numbers
    1 day ago
  • FDA - Press Releases
    FDA Grants Two National Priority Vouchers
    4 days ago
  • Quality Matters
    Extractables and Leachables Testing: Driving Global Standards Through Dialogue
    5 days ago
  • Pharmafile
    STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases
    5 days ago
  • Drug Channels
    Drug Channels News Roundup, December 2025: The Net Pricing Drug Channel (#NPDC) Era, LillyDirect, My $0.02 on New MFPs, PBMs in Medicaid—and DCLF 2026
    5 days ago
  • Pharmafile - Mfg & Production
    Norgine enters exclusive licensing agreement with Vir Biotechnology
    5 days ago
  • JD Supra Law News
    Navigating the AI Frontier: Legal Guardrails for Home Health and Hospice Providers in 2025 and Beyond
    1 week ago
  • World Pharma - Breaking News
    New study finds cystic fibrosis drug allows patients to safely scale back lung therapies
    1 week ago
  • The Incidental Economist
    When Drug Price Transparency Isn’t Enough
    2 weeks ago
  • Asbestos and Mesothelioma News
    RFK Jr. Signs Pullback of Asbestos Test Proposal for Talc Cosmetics
    2 weeks ago
  • Healthcare Packaging
    Practical Waste Recycling at the Hospital Level: What Are the Odds?
    4 weeks ago
  • Clinical Correlations
    Guideline Gap: Are We Failing High-Risk Women in Breast Cancer Prevention?
    5 weeks ago
  • 33 Charts
    The AI coding arms race
    1 month ago
  • Ted Eytan, MD
    Virgin Voyages Valiant Lady
    1 month ago
  • The Compliance and Ethics Blog
    Why Compliance Is the Cornerstone of Ethical Medical Billing
    2 months ago
  • FDA - Health Fraud
    BIG GUYS Male Energy Supplement contains hidden drug ingredient
    4 months ago
  • Mobihealthnews
    Mendaera gets FDA 510(k) clearance for handheld robotic system
    5 months ago
  • SkillsPlus International Info
    FDA Rushed Out AI Tool
    6 months ago
  • The Health, Drug, Prescription, and GMP Supersite
    Designated Representative Training - California | State-Approved
    6 months ago
  • Modern Healthcare News
    Meet the Administration for a Healthy America, HHS' newest agency
    6 months ago
  • Designated Representative and Exemptee
    Designated Representative Training | Board-Approved Courses | Recommended
    8 months ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    9 months ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    10 months ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    10 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    10 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    10 months ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    11 months ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    1 year ago
  • Healthy Travel Blog
    Hello world!
    1 year ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    1 year ago
  • Eye on FDA
    FDA Adds New AdComm to Address Genetic Metabolic Diseases
    1 year ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    1 year ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    1 year ago
  • Medgadget
    Plant-Based Soft Medical Robots
    2 years ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    2 years ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    2 years ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    2 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    3 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    3 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    6 years ago
Show 5 Show All

Blog Archive

  • ►  2025 (1)
    • ►  June (1)
  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ▼  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ▼  June (2)
      • California Designated Representative Training Cour...
      • COVID-19 - How To Protect Yourself And Others - CD...
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ►  2013 (127)
    • ►  December (7)
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo